School of Medicine
Showing 101-150 of 225 Results
-
Allison W. Kurian, M.D., M.Sc.
Professor of Medicine (Oncology) and of Epidemiology and Population Health
Current Research and Scholarly InterestsI aim to understand cancer burden and improve treatment quality at the population level. I have a strong focus on genetic risk assessment and precision oncology. I lead epidemiologic studies of cancer risk factors, clinical trials of novel approaches to cancer risk reduction, and decision analyses of strategies to optimize cancer outcomes.
-
Lianne Kurina
David and Lucile Packard Foundation Professor of Human Biology and Professor (Teaching), by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy recent research has focused on the physical and mental health of military service members. I'm now working with colleagues at the VA.
-
Angelle Desiree LaBeaud
Professor of Pediatrics (Infectious Diseases), Senior Fellow at the Woods Institute for the Environment and Professor, by courtesy, of Epidemiology and Population Health and of Environmental Social Sciences
Current Research and Scholarly InterestsArthropod-borne viruses are emerging and re-emerging infections that are spreading throughout the world. Our laboratory investigates the epidemiology of arboviral infections, focusing on the burden of disease and the long-term complications on human health. In particular, Dr. LaBeaud investigates dengue, chikungunya, and Rift Valley fever viruses in Kenya, where outbreaks cause fever, arthritis, retinitis, encephalitis, and hemorrhagic fever. Our main research questions focus on the risk factors for arboviral infections, the development of diagnostic tests that can be administered in the field to quickly determine what kind of arboviral infection a person has, and the genetic and immunologic investigation of why different people respond differently to the same infection. Our long-term goals are to contribute to a deeper understanding of arboviral infections and their long-term health consequences and to optimize control strategies to prevent these emerging infections. Our laboratory also investigates the effects of antenatal and postnatal parasitic infections on vaccine responses, growth, and development of Kenyan children.
My lab at Stanford supports the field work that is ongoing in Kenya, but we also have several projects that are based locally. We strive to improve diagnostics of arboviral infections and are using Luminex technology to build a new screening assay. We also have created a Luminex based platform to assess vaccine responses against multiple pathogens. -
Tracy Lam-Hine
Postdoctoral Scholar, Epidemiology
BioTracy Lam-Hine (he/him), DrPH, MBA, is a postdoctoral scholar in the Department of Epidemiology and Population Health and the Center for Population Health Sciences, a Research Education Component Fellow at the Stanford Alzheimer's Disease Research Center, and is affiliated via a Research Fellowship with the Temple University Center for Public Health Law Research. Dr. Lam-Hine is a social epidemiologist and population health scientist, studying how exposure to adverse childhood experiences, policy environments, and mid-life chronic disease burden shape the risk cognitive and functional aging in later life. Within this broad research area, he has a special focus on the health and social experiences of the US Multiracial population, surveillance data, methods to improve descriptive and population-generalizable research.
-
Marvin Langston
Assistant Professor of Epidemiology and Population Health and, by courtesy, of Urology
BioDr. Marvin Langston is an Assistant Professor of Epidemiology and Population Health. He is a member of the Stanford Cancer Institute and Urologic Cancer Epidemiology Lab. He is an epidemiologist by training who focuses on the fields of benign prostate and pelvic conditions and urological cancers including prostate and kidney cancers.
Prior to Stanford, he served as a Research Scientist in the Division of Research at Kaiser Permanente Northern California. Dr. Langston received his PhD in Epidemiology from the University of Arizona’s College of Public Health followed by postdoctoral training in Cancer Prevention and Control at Washington University in Saint Louis School of Medicine.
His program of research intends to characterize and measure infectious agents, environmental toxicants, and lifestyle factors; to evaluate the role of these factors in urological cancer etiology and outcomes; and to identify populations at high risk of exposure to these factors. So far he has focused this research to address the following questions: 1) What role do sexually transmitted infections and other systemic infections have in prostate damage and ensuing prostate cancer risk? 2) How can we appropriately model and define early life risk factors for urological cancers? 3) Can we harmonize molecular and clinical aspects of urological condition diagnoses to produce well characterized outcomes for biomarker discovery and etiological investigation? He has primarily addressed these questions using a variety of molecular and clinical epidemiology approaches while developing expertise in the cross-cutting theme of cancer health disparities with particular interests in the cancer care experiences of sexual and gender minorities and racial/ethnic minorities.
Dr. Langston has been studying the impact of exogenous factors on prostate specific antigen (PSA) concentration in young men as a marker of prostate damage and inflammation for over a decade. As early life PSA has been found predictive of future prostate cancer mortality, he has now setout to optimize risk-stratified screening for prostate cancer. This promising approach uses men’s baseline PSA values to inform their risk of future aggressive and/or fatal prostate cancer and determine their frequency of further screening. Under this approach, men with high baseline age-specific total PSA levels receive more frequent screening and men with lower levels receive less frequent screening. Dr. Langston was awarded an R01 from NCI to evaluate this approach using historically collected biospecimen. His funded research trajectory to this point also includes four training awards (2-NCI and 2-NIDDK) and several internal grants. Dr. Langston was selected in the inaugural class of the White House Cancer Moonshot Scholars for his work. -
Jennifer Lee
Professor of Medicine (Endocrinology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsI am a healthcare lead and physician scientist for innovation, R&D, and advanced analytics, and oversee these aspects at VA Palo Alto/VHA, within Stanford-VA relationship. The VA has the US's largest health care system and longest running EHR. I prioritize enabling multiple partners (industry, government, academia, foundations), to innovate/R&D in the VA health care system. We prioritize mentoring students from various Schools to become future leaders in R&D, innovation, and healthcare.
-
Mary Leonard
Arline and Pete Harman Professor, Professor of Pediatrics (Nephrology), of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy multidisciplinary research program is focused on (1) the detrimental effects of glucocorticoids, sarcopenia and inflammation on bone development in pediatric diseases, (2) the long-term effects of childhood cancer on bone and muscle quality, (3) the assessment of renal osteodystrophy using novel micro-imaging techniques, (4) the effects of vitamin D deficiency on physical function and cardiovascular disease, and (5) the evaluation of biomechanical interventions as anabolic bone therapies.
-
Zongbo Li
Postdoctoral Scholar, Health Policy
BioZongbo Li, PhD, is a postdoctoral researcher at Stanford Health Policy. His research focuses on applying simulation modeling and cost-effectiveness analysis to inform policy decisions related to substance use and infectious diseases. He evaluates overdose prevention interventions, including naloxone distribution and medications for opioid use disorder, with particular attention to vulnerable populations such as people who are incarcerated. His work also encompasses modeling infectious diseases and evaluating interventions for COVID-19, HIV, and HCV. Zongbo earned his PhD in Health Services Research, Policy & Administration from the University of Minnesota.
-
Richard Liang
MD Student with Scholarly Concentration in Health Services & Policy Research / Global Health, expected graduation Spring 2026
Ph.D. Student in Epidemiology and Clinical Research with Scholarly Concentration in Health Services & Policy Research / Global Health, admitted Autumn 2022
MSTP Student
Master of Arts Student in East Asian Studies, admitted Spring 2024Current Research and Scholarly InterestsPrimary research interests include:
- applications of advanced epidemiological methods
- life course health and social epidemiology
- bridging population health and basic science research
Clinical & health services research topics have included:
- maternal/child health
- geriatrics/aging
- dermatology, particularly inflammatory skin diseases -
Eleni Linos, MD, MPH, DrPH
Ben Davenport and Lucy Zhang Professor of Medicine, Professor, of Medicine (Center for Digital Health) and, by courtesy, of Epidemiology and Population Health
BioEleni Linos MD, MPH, DrPH, is the Director of the Stanford Center for Digital Health. She is a Professor of Dermatology and Epidemiology at Stanford University. Dr. Linos also serves as an Associate Dean for Research at Stanford Medicine, leading the training and mentoring of the next generation of translational research scientists.
Dr. Linos' research focuses on the use of technology in health, dermatology, public health, cancer prevention and the care of older adults. She is dually trained in epidemiology and dermatology and is the principal investigator of several NIH funded studies aimed at improving the lives of patients worldwide. She received her undergraduate degree from Trinity College, Cambridge and medical degree from Christ Church College, Oxford University in the UK. She then received a master’s and doctoral degree from the Harvard School of Public Health and completed her residency in Dermatology at Stanford University.
Linos has been continuously funded by the NIH since 2016, as principal investigator of several studies on technology, aging and dermatology. Her scholarly output includes over 200 peer-reviewed publications, an h-index of 51, and more than 10,000 citations across disciplines. Linos was awarded the NIH Director’s New Innovator Award and received the Paul Beeson Emerging Leaders Award in Aging.
As the Director of the Stanford Center for Digital Health, she has built and led infrastructure bringing together scientists and industry leaders across all Stanford schools to catalyze research across the fields of medicine, computer science, engineering, robotics, policy and public health.
Dr. Linos is committed to mentorship and training of the next generation of scientists in translational research. She has personally mentored over 60 physician-scientists, many of whom are now independently-funded investigators and leaders in academic medicine. She also serves as the co-PI of Stanford CTSA’s K12 Program, responsible for mentorship and training of 10 translational science faculty each year. Over the last seven years, she is funded by an NIH K24 mentorship grant award to mentor the next generation of physician-scientists in dermatology. In addition, Linos is committed to mentorship and supporting students across all levels of education to pursue their passions including students in high school and undergraduates.
Clinically, Dr. Linos is a Board Certified Dermatologist and cares for patients with skin disease in the Stanford Dermatology teaching clinics. -
Lili Liu
Postdoctoral Scholar, Epidemiology
BioLili (Larry) Liu, PhD, is a postdoctoral fellow in the Department of Epidemiology & Population Health at Stanford University. As an integrative epidemiologist, Dr. Liu unifies molecular biomarkers, large-scale population cohorts, and real-world health data into coherent, hypothesis-driven research with a sustained focus on how early-life exposures, genetic variation, lifestyle, and pharmacological factors shape inflammation, biological aging, and chronic disease risk across the life course. Trained in cancer genetic and nutrition epidemiology with complementary expertise in pharmacoepidemiology, his doctoral research at Vanderbilt University included a multi-ancestry GWAS of urinary prostaglandin E2 metabolite (PGE-M), development of PGE-M–derived dietary and lifestyle scores via elastic net with extensive bootstrapping, and Mendelian randomization analyses linking PGE-M to colorectal cancer across ancestries. At Stanford, Dr. Liu extends his research to maternal–fetal and placental epidemiology, building nationwide claims-based pregnancy cohorts (e.g., MarketScan) to examine gestational diabetes and downstream liver disease risk, and creating mother–infant pair cohort to investigate systemic antibiotic exposure in relation to subsequent inflammatory bowel disease and celiac disease. Parallel collaborations focus on extracellular vesicles and angiogenic signaling in placental health. Methodologically, Dr. Liu works at the interface of causal inference, pharmacoepidemiology, and machine learning with reproducible data engineering (R/Python, SQL, HPC), with the overarching goal of translating mechanistic insights into actionable biomarkers and risk tools for chronic disease prevention in diverse populations.
-
Nathan Lo
Assistant Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsOur research group is interested in studying the transmission of infectious diseases and impact of public health interventions with an ultimate goal of informing public health policy. We study a diverse set of pathogens, both domestically and internationally, including vaccine-preventable infections (including COVID-19) and neglected parasitic diseases (such as schistosomiasis). Our group applies diverse computational methodologies, including tools from fields of epidemiology, mathematical and statistical modeling, simulation, and policy analysis.
A large emphasis of our work is translating scientific evidence into public health policy. Our track record includes multiple studies that have changed policy in the fields of neglected parasitic diseases and COVID-19. We work closely with policy organizations like the World Health Organization and the California Department of Public Health. Nathan was the lead writer of the World Health Organization guidelines on schistosomiasis (2022) and strongyloidiasis (2024).
Our current research focuses on the following areas:
(1) Vaccine-preventable infectious diseases (including COVID-19 and measles) in the United States, with a focus on studying vaccines, transmission dynamics, and re-emergence of vaccine-eliminated diseases
(2) Public health strategies for control and elimination of globally important neglected infectious diseases, such as helminths infections (schistosomiasis, strongyloidiasis) and typhoid fever
Our current NIH funded projects include:
(1) Real-time predictive modeling for public health departments to control infectious diseases (DP2 AI170485, PI: Lo)
(2) Precision mapping of Schistosoma mansoni risk for targeted public health control and elimination (R01 AI179771, PI: Lo)
Hiring
We are seeking to fill multiple research positions at all levels. Candidates interested in working on computational public health research related to infectious diseases with a strong quantitative background are highly encouraged to apply. If you an interested, please submit a cover letter, CV, and names of two references to Nathan.Lo@stanford.edu. -
Junjie Lu
Ph.D. Student in Epidemiology and Clinical Research, admitted Autumn 2023
BioJunjie's research is centered on the social determinants of minority health, epidemiological methods, and clinical effectiveness. He is deeply committed to understanding the health disparities faced by minority populations. His clinical background helps bridge the gap between research and practical application, aiming to improve healthcare outcomes in real-world settings.
Junjie Lu earned a Master of Public Health degree from the Harvard T.H. Chan School of Public Health, where he concentrated on Health and Social Behavior. He also holds an MBBS and an MS from Shanghai University of Traditional Chinese Medicine. Junjie gained practical experience as an intern doctor at a university hospital for two years, during which he led a pilot randomized controlled trial on the effects of acupuncture on depressive symptoms. -
Ying Lu
Professor of Biomedical Data Science and, by courtesy, of Epidemiology
Current Research and Scholarly InterestsBiostatistics, clinical trials, statistical evaluation of medical diagnostic tests, radiology, osteoporosis, meta-analysis, medical decision making
-
Stephen Luby
Lucy Becker Professor of Medicine, Senior Fellow at the Woods Institute for the Environment, Freeman Spogli Institute for International Studies and Professor, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Luby’s research interests include identifying and interrupting environmental pathways of disease in low- and middle-income countries.
-
Mitchell R. Lunn
Associate Professor of Medicine (Nephrology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsLGBTQIA+ health
-
David Maahs
Lucile Salter Packard Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health
On Partial Leave from 02/09/2026 To 03/10/2026BioDr David M. Maahs is the Lucile Salter Packard Professor of Pediatrics, Division Chief of Pediatric Endocrinology, and Associate Chair for Academic Affairs in Pediatrics at Stanford University and the Lucile Packard Children’s Hospital. He earned his MD followed by Pediatric Residency at the University of New Mexico. After 3 years on New Mexico’s faculty, Dr. Maahs completed a Pediatric Endocrinology fellowship and a concurrent PhD in Epidemiology at the University of Colorado. He remained on Colorado’s faculty for 10 years, advancing to Professor of Pediatrics before moving to Stanford. Prior to his medical career, Dr. Maahs received a BA and MA in English from the University of Kansas and was inspired to pursue a medical career after serving in the Peace Corps with assignments in Tunisia and the Central African Republic.
Dr. Maahs’ leadership experiences include being a past co-Chair (2013-16) for Protocols and Publications with the Type 1 Diabetes Exchange for which he continues as Director of International Collaborations. This complements his role as President-elect for the International Society of Pediatric and Adolescent Diabetes (ISPAD, 2021-25) and Editor-in-Chief for the 2018 ISPAD Clinical Practice Consensus Guidelines. He served on the Professional Practice Committee for the American Diabetes Association (ADA, 2016-18), which writes the annual ADA Standards of Care. Previously, he served on the ADA Scientific Sessions committee representing the Council on Youth. He has also served on national committees for the American Heart Association, the Pediatric Endocrine Society, and multiple journal editorial boards and review committees.
His scholarly interest is improving care and preventing complications in people with type 1 diabetes (T1D). Along with Dr Peter Chase, he is author of the 12th and 13th editions of Understanding Diabetes, or ‘Pink Panther,’ which are the most widely used educational books for children newly diagnosed with T1D, distributed internationally by the Juvenile Diabetes Research Fund (JDRF). More specifically, he has conducted epidemiologic studies that help generate hypotheses for clinical studies, including trials to develop artificial pancreas systems to improve glucose control, lower disease burden, prevent the complications of diabetes, and reduce disparities in diabetes care. He is author or co-author of over 350 research publications. His multi-disciplinary research has been funded by the JDRF, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), the Helmsley Charitable Trust, and the National Science Foundation (NSF).
Dr Maahs is Associate Director for the recently formed and NIDDK P30 funded Stanford University Diabetes Research Center (https://sdrc.stanford.edu). His collaborations extend to his role as Principal Investigator (PI) or steering committee member for NIH funded multi-center clinical trials including the FLEX, PERL, and ACTION studies as well as multiple Artificial Pancreas clinical trials. Education, mentorship, and training leadership includes being Program Director with Dr. Georgeanna Klingensmith on the Barbara Davis Center T32 and K12 training grants in Pediatric Endocrinology while at the University of Colorado. He is the PI on the Stanford NIH funded K12 "Training Research Leaders in Type 1 Diabetes.' Dr Maahs is also the Associate Chair for Academic Affairs for the Department of Pediatrics.
While in the Peace Corps, David met his wife, Christine Walravens, who is also a Pediatrician at Stanford. They enjoy outdoor activities and traveling with their adult children. -
Yvonne Maldonado
Vice Provost for Faculty Advancement, Taube Professor of Global Health and Infectious Diseases, Professor of Pediatrics (Infectious Diseases) and of Epidemiology and Population Health
Current Research and Scholarly InterestsMy research focuses on epidemiologic aspects of viral vaccines and perinatal HIV infection. This includes the molecular epidemiology of factors affecting the immunogenicity of oral polio vaccine (OPV) in developing areas of the world, and now the epidemiology of transmission and circulation of vaccine derived polioviruses in order to assist in global eradication of polio. I also work in development of methods to prevent breastfeeding transmission of HIV in Africa.
-
Mario Malički
Social Science Research Scholar, Epidemiology and Population Health
Current Role at StanfordAssociate Director of Stanford Program of Research Rigor and Reproducibility (SPORR)
-
Maya Mathur
Associate Professor (Research) of Pediatrics, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases
-
Himaja Nagireddy
Ph.D. Student in Health Policy, admitted Autumn 2025
BioHimaja Nagireddy (she/her) is a PhD student in Health Policy at Stanford. She previously served as a Program Manager at the Kennedy Krieger Institute, an affiliate of the Johns Hopkins School of Medicine, in Baltimore, MD.
Prior to this, Himaja served as the Deputy Associate Policy Director for First Lady Dr. Jill Biden at the White House, Briefings Manager for the Harris-Walz campaign, and Research Fellow at the CDC’s Agency for Toxic Substances and Disease Registry (ATSDR). She also served as the 11th Youth Observer to the UN from 2022-23. Himaja graduated with an MS in Environmental Epidemiology and a concentration in Infectious Disease Epidemiology from the Harvard T.H. Chan School of Public Health in 2022, and her bachelor’s degrees in Physiology and Neurobiology, Molecular and Cell Biology, and Sociology from the University of Connecticut in 2020. -
Lorene Nelson, PhD, MS
Professor of Epidemiology and Population Health, Emerita
Current Research and Scholarly InterestsPrimary research interests:
- genetic, environmental and lifestyle determinants of neurodegenerative disorders
(amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, migraine)
- innovative study design and data ecosystems in clinical and public health
Primary educational interests:
- Training of next generation scientists in advanced data science and analytic methods
in population, social, and behavioral health sciences. -
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Chloe Nobuhara
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2025
BioChloe Nobuhara is a fourth year general surgery resident at Stanford University, currently doing two years of research in acute care surgery and a Masters in Epidemiology. She completed her undergraduate studies at Northeastern University and her MD at Duke University School of Medicine. Prior to that, she worked at MGH studying Alzheimer's disease which spurred her interest in neuroscience. Her research interests include post-operative delirium, robotic surgery, and the application of machine learning and computer vision to surgical video review.
-
Juno Obedin-Maliver
Associate Professor of Obstetrics and Gynecology (Gynecology & Gynecologic Specialties/Generalist) and, by courtesy, of Epidemiology and Population Health
BioJuno Obedin-Maliver, MD, MPH, MAS, FACOG (she/her) is an Associate Professor in the Department of Obstetrics and Gynecology at Stanford University School of Medicine.
Dr. Juno Obedin-Maliver is a board-certified obstetrician/gynecologist who provides excellent clinical care, while advancing scientific knowledge through her research, and supporting personal and professional development as a physician coach.
She practices full-spectrum gynecology including outpatient, in-patient, operative, and emergency care services. This specifically includes collaborative management of cervical dysplasia and abnormal pap smears, abnormal uterine bleeding, contraception and family planning, pelvic pain, abnormal discharge, sexually transmitted infection testing and treatment, and more. She specializes in the gynecological and reproductive health care needs of sexual and gender minority people which include but are not limited to lesbian, gay, bisexual, transgender, queer and questioning (LGBTQ+) people. This interest and experience drives her research interests towards promoting the health and well-being and equity of LGBTQ people.
Dr. Obedin-Maliver, is the Co-Director of The PRIDE Study (pridestudy.org), a multi-site online prospective longitudinal cohort of sexual and gender minority individuals based at Stanford. She also serves on the medical advisory board of the University of California San Francisco Center of Excellence for Transgender Health and is helping to author the next version of the World Professional Association for Transgender Health (WPATH) Standards of Care. Dr. Obedin-Maliver has also been active in health policy, including involvement in helping to legally redefine consideration of sexually intimate partner status and to remove the Medicare Non-Coverage Determination ruling on gender -affirming surgeries.
Additionally, Dr. Obedin-Maliver continues her long-standing commitment to growth, healing, and empowerment as a Master Certified Physician Development Coach (Physician Coaching Institute, ICF Level I). In her coaching, Dr. Obedin-Maliver uses personal and professional development tools, mindfulness, and somatic frameworks to enhance health, agency, and creativity in partnering with individuals to help them achieve their professional goals and design their personal lives. She rejoices in partnering with diverse healthcare providers to use her broad skills to supercharge their authentic learning and growth, especially in times of challenge and resistance.
For more information about her research and career, please see: pridestudy.org and http://med.stanford.edu/obedin-maliver.html -
Michelle Odden
Associate Professor of Epidemiology and Population Health
Current Research and Scholarly InterestsMultilevel - from cells to society - epidemiologic study of healthy aging
